Dr. Ashley Whitaker joined the Children's Center for Cancer and Blood Diseases at CHLA after completing an APA-accredited pediatric neuropsychology track internship at the Barrow Neurological Institute at Phoenix Children's Hospital and a two-year APPCN-accredited postdoctoral fellowship in pediatric neuropsychology at The Children's Hospital of Philadelphia. Dr. Whitaker specializes in neuropsychological evaluation of children and adolescents with conditions related to oncology, inborn errors of metabolism, and leukodystrophies. She is devoted to training and enjoys supervising neuropsychology trainees and medical students with regard to brain-behavior relationships.
Dr. Whitaker holds an appointment as Assistant Professor of Clinical Pediatrics at the Keck School of Medicine of University of Southern California. Her research is focused on neuropsychological sequelae of rare metabolic disorders, oncologic conditions, and pediatric epilepsy, as well as implications of bilingualism on neuropsychological functioning in medically compromised populations.
Neuropsychological implications of medical conditions related to pediatric oncology (including evaluation for pre- and post-transplantation, solid brain tumor, and late-effects of chemotherapy and radiation), hematology, stroke, and metabolic disease.
Alliant International University, Los Angeles: Clinical Psychology
Phoenix Children's Hospital/Barrow Neurological Institute: Pediatric Neuropsychology Track
The Children's Hospital of Philadelphia/University of Pennsylvania Biomedical Postdoctoral Program: Pediatric Neuropsychology
International Neuropsychological Society (INS)
American Academy of Clinical Neuropsychology (AACN)
American Psychological Association (APA)
Division 40: Clinical Neuropsychology
Long-term neuropsychological sequelae of various medical conditions and treatment protocols, as well as the role of bilingualism in medically fragile populations.